Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2010

View Archived Issues

Phase IIa data disclosed on tideglusib in Alzheimer's disease

Novartis reviews second quarter of 2010

EVP-0015962 improves cognitive deficit in mouse model of Alzheimer's disease

PDIP-38 is a candidate biomarker for progression of HPV-16-associated cervical dysplasia

Insulin degludec improves glucemic control in phase II trials in type 1 and 2 diabetes

Drug-targetable rearrangements of RAF kinase pathway members identified in prostate cancer

Repros Therapeutics to start low-dose study of Proellex

Tarsa advances phase III oral calcitonin trial in postmenopausal osteoporosis

Enrollment begins in phase II MM-121 trial in breast cancer

NACI updates recommendations on rotavirus vaccination in Canada

University of Michigan claims new STAT-3 inhibitors

AiCuris discloses new anti-HIV agents

Algeta concludes manufacture and supply agreements for alpharadin

S/GSK-1265744 is active against RAL-resistant HIV isolates in vitro

Fresenius Medical Care expands its dialysis products business

FDA grants CBLB-502 fast track status for acute radiation syndrome

DSMB recommends completion of phase II FV-100 trial in shingles

NPS Pharma advances phase III trial of teduglutide in short bowel syndrome

ConjuChem Biotechnologies files for bankruptcy

CP-404 successfully completes pilot phase I study for obesity

CHMP concludes topical ketoprofen has positive benefit-to-risk balance

Euthymics Bioscience acquires DOV Pharma and continues EB-1010 development

MDRNA shareholders approve Cequent acquisition and name change to Marina Biotech

Korean scientists discover new cyclic penta-depsipeptides

Sirtris Pharmaceuticals describes new SIRT modulators

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...